At the center of the debate are the growing number of manufacturer demands for claims data as a condition of 340B pricing. Zaid Fadul, MD, FS, FAAFP, introduces the Nolla Derm app, what it might mean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results